Developing and validating NAFLD advanced fibrosis diagnostic prediction model in primary care
Developing and validating NAFLD advanced fibrosis diagnostic prediction model in primary care
批准号:
402930
负责人:
Shaheen Abdel-Aziz M
金额:
$19.84万
依托单位:
依托单位国家:
加拿大
项目类别:
Operating Grants
财政年份:
2019
资助国家:
加拿大
项目状态:
已结题
起止时间:
2019-03-01 至 2023-03-01
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Non-alcoholic fatty liver disease (NAFLD), commonly called fatty liver, has become the leading cause of chronic liver disease in North America. It is estimated that up to 24% of Canadian population has NAFLD. NAFLD will become the main cause of end stage
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Evaluate, validate and refine the first clinical care pathway to risk-stratify patients with alcohol-related liver disease
-
批准号:470000
-
项目类别:Operating Grants
-
资助金额:$33.16万
-
财政年份:2022
-
负责人:Shaheen Abdel-Aziz M
-
依托单位:
Understanding and Responding to the COVID-19 Pandemic Effect on the Magnitude of Alcohol-Related Liver Disease in Alberta.
-
批准号:460228
-
项目类别:Operating Grants
-
资助金额:$30.81万
-
财政年份:2021
-
负责人:Shaheen Abdel-Aziz M
-
依托单位:
海外基金